Sort
261,768 grants matching “gene therapy”
VDX-111: A novel targeted therapeutic for triple-negative breast cancer
$995,137Hamid H Gari · Vona Oncology, Llc · R44 · FY2023 · CA
VDX-111: A novel targeted therapeutic for triple-negative breast cancer
$995,137Cherie Lambert · Vona Oncology, Llc · R44 · FY2024 · CA
Aerosolized Vitamin A: Developing a Prevention for Hyperoxic Lung Injury and Bronchopulmonary Dysplasia, with Focus on Neonatal Lung Maturation
$995,121Craig Gelfand · Advent Therapeutics, Inc. · R44 · FY2023 · HL
Immunotherapy for Malignant Mesothelioma, Lung Cancer and Thymic Malignancies
$995,112Raffit Hassan · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Development of VNLG-152R as novel therapeutic for triple negative breast cancer
$995,100Vidya P Ramamurthy · Isoprene Pharmaceuticals, Inc. · R44 · FY2022 · CA
Development of VNLG-152R as novel therapeutic for triple negative breast cancer
$995,100Vidya P Ramamurthy · Isoprene Pharmaceuticals, Inc. · R44 · FY2021 · CA
CureGN-Penn PCC
$994,944Lawrence B. Holzman · University Of Pennsylvania · U01 · FY2025 · DK
Tumor Immune Contexture and Breast Cancer Disparities: A Multi-Disciplinary Study in Women of African and European Ancestry
$994,901Christine B. Ambrosone · Roswell Park Cancer Institute Corp · R01 · FY2020 · CA
Genotoxicity and mitochondrial toxicity of antiretroviral NRTI and PI drugs
$994,899Miriam C Poirier · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Boosting Innate Immunity Through HIF to Treat Antibiotic-Resistant Infections
$994,866Victor Nizet · University Of California, San Diego · R01 · FY2012 · AI
CTO1681 to prevent and mitigate cytokine release syndrome in CAR T-cell recipients
$994,859Arthur P Bertolino · Cytoagents, Inc. · R44 · FY2024 · CA
NovaSeq6000
$994,850Vicki Huff · University Of Tx Md Anderson Can Ctr · S10 · FY2018 · OD
Providing GMP-grade Terbium-161 as a therapeutic option for US academic institution
$994,810Ian Horvath · Fusion Energy Solutions, Inc. D/B/A Serva Energy · R44 · FY2025 · CA
Gene corrected iPS-derived lung cells for therapy of inherited lung diseases
$994,635Brian R. Davis · University Of Texas Hlth Sci Ctr Houston · RC1 · FY2010 · HL
Rapid Analysis of Single Nucleotide Polymorphism Genotypes in AIDS Cohorts
$994,571Stephen J O'Brien · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
BAY AREA BREAST CANCER TRANSLATIONAL RESEARCH PROGRAM
$994,561University Of California San Francisco · P50 · FY2002 · CA
Subingual-parenteral Vaccination to Prevent Oral HIV Transmission in Infants
$994,542Kristina Abel · Univ Of North Carolina Chapel Hill · R01 · FY2018 · DE
Chromosomal Proteins and Chromosomal Functions
$994,541Michael Bustin · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Human Polycystic Kidney Disease
$994,516University Of Colorado Denver · P01 · FY2003 · DK
Genomic Diagnosis and Individualized Therapy of Highly Penetrant Genetic Diabetes
$994,510Toni I. Pollin · University Of Maryland Baltimore · U01 · FY2016 · HG
Engineering a Human Microphysiological System for the Characterization of Islet-Immune Interactions
$994,468Cherie L Stabler · University Of Florida · UH3 · FY2023 · DK
i-AKC: Integrated AIRR Knowledge Commons
$994,460Lindsay G. Cowell · Ut Southwestern Medical Center · U24 · FY2024 · AI
Pathophysiology of Human Blood Cells
$994,372David A Williams · Boston Children'S Hospital · T32 · FY2023 · HL
Mouse Auditory Testing Core Facility
$994,357Tracy Fitzgerald · National Institute On Deafness And Other Communication Disorders · ZIC · FY2023 · DC
Role of HIV Envelope Proteins In Viral Replication and HIV Pathogenesis
$994,320Claudia Cicala · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI